Notify me when Atlas Venture Fund XII, L.P. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| JBIO | JADE BIOSCIENCES, INC. | Common Stock | 0.2% | $521,257 | 51,406 | Atlas Venture Associates XII, L.P. | 28 Apr 2025 | ||
| VIGL | VIGIL NEUROSCIENCE, INC. | Common Stock, $0.0001 par value per share | 0% | $0 | 0 | Atlas Venture Fund XII, L.P. | 05 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|